Support resources and services for the use of annotated patient-derived (PD) models including xenografts (PDX) and organoids (PDO) models for research that make an impact in precision cancer medicine.
Supports the bioproducts, bioscience, bioagriculture and chemical manufacturing sectors through research and innovation, testing and prototyping, and training.